<DOC>
	<DOCNO>NCT01987960</DOCNO>
	<brief_summary>To evaluate efficacy brexpiprazole adjunctive treatment paroxetine ( PAR ) sertraline ( SER ) PTSD symptom .</brief_summary>
	<brief_title>Brexpiprazole Adjunctive Treatment Paroxetine Sertraline Adult Patients Suffering From Post-traumatic Stress Disorder ( PTSD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Brexpiprazole</mesh_term>
	<criteria>The patient PTSD , diagnose accord DSMIVTR™ confirm Mini International Neuropsychiatric Interview ( MINI ) . The patient ClinicianAdministered PTSD Scale Part 2 ( CAPS2 ) total score ≥70 Screening Baseline Visits . The reported duration PTSD least 3 month . The index traumatic event lead development PTSD take place 15 year screen . The patient severe personality disorder investigator 's opinion may interfere conduct study . The patient significant suicidal risk . Other inclusion exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>